Dergiler / Bezmiâlem Science / 2019 / Cilt: 7 - Sayı: 2

Extra-Parenchymal Chest HRCT Findings in Patients with Systemic Sclerosis at the Time of Initial Diagnosis

Sayfa
101–106
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Esophageal dilatation is usually present at the time of diagnosis in most patients with SS regardless of age.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: In systemic sclerosis (SS) patients who are receiving treatment, findings of extra-parenchymal chest involvement (such as thymic abnormality, mediastinal lymph node enlargement) have been previously examined.
📊
Temel Bulgular & Veri:Chest HRCT images within 1 month after initial diagnosis of these patients were re-evaluated for the presence of distal esophageal dilatation, thymic hyperplasia, mediastinal lymph node enlargement, pleural or pericardial abnormalities (effusion or thickening).
💡
Sonuç & Katkı:Esophageal dilatation is usually present at the time of diagnosis in most patients with SS regardless of age.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: In systemic sclerosis (SS) patients who are receiving treatment, findings of extra-parenchymal chest involvement (such as thymic abnormality, mediastinal lymph node enlargement) have been previously examined. However, these findings may be affected by medical treatment. Our aim was to evaluate the extra-parenchymal chest high-resolution computed tomography (HRCT) findings of patients with SS at the time of initial diagnosis. Methods: We retrospectively analyzed medical database of patients with SS. Chest HRCT images within 1 month after initial diagnosis of these patients were re-evaluated for the presence of distal esophageal dilatation, thymic hyperplasia, mediastinal lymph node enlargement, pleural or pericardial abnormalities (effusion or thickening). Intergroup comparisons were performed using independent t-test or a Mann-Whitney U test. To detect the relationship between continuous variables, Spearman’s correlation coefficients and univariate correlations were used. Results: A total of 51 patients (45 women and 6 men, mean age + STD; 49.2 years+13.9) with SS were included in the study. Esophageal dilatation (88.2%) was the most common finding. Six patients (11.8%) had thymic enlargement. Mediastinal lymph node enlargement (11.8%) and pleural abnormalities (11.8%) were significantly more common in patients with SS diagnosed at late age (p<0.05). Conclusion: The extra-parenchymal findings are common in patients with SS at the time of initial diagnosis. Esophageal dilatation is usually present at the time of diagnosis in most patients with SS regardless of age.

🔖

Bu Makaleye Atıf Yap

UFUK, F., ÇAKMAK, P., SAĞTAŞ, E., ÇOBANKARA, V., YAĞCI, A. B. (2019). Extra-Parenchymal Chest HRCT Findings in Patients with Systemic Sclerosis at the Time of Initial Diagnosis. Bezmiâlem Science, Cilt: 7 - Sayı: 2, 101–106. https://ajindex.com/articles/143758

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Amin DV, Lozanne K, Parry PV, Engh JA, Seelman K, Mintz A: Image-guided frameless stereotactic needle biopsy in awake patients without the use of rigid head fixation. J Neurosurg 2011;114:1414-20.
  2. Chen CC, Hsu PW, Erich Wu TW, Lee ST, Chang CN, Wei KC, et al. Stereotactic brain biopsy: Single center retrospective analysis of complications. Clin Neurol Neurosurg 2009;111:835-9.
  3. Dammers R, Haitsma IK, Schouten JW, Kros JM, Avezaat CJ, Vincent AJ. Safety and efficacy of frameless and frame-based intracranial biopsy techniques. Acta Neurochir (Wien) 2008;150:23-9.
  4. Ferreira MP, Ferreira NP, Pereira Filho Ade A, Pereira Filho Gde A, Franciscatto AC. Stereotactic computed tomography-guided brain biopsy: diagnos- tic yield based on a series of 170 patients. Surg Neurol 2006;65 Suppl 1:S1:27-1:32. Hall WA: The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer 1998;82:1749-55.
  5. Kim JE, Kim DG, Paek SH, Jung HW. Stereotactic biopsy for intracranial lesions: reliability and its im- pact on the planning of treatment. Acta Neurochir (Wien) 2003;145:547-54.
  6. McGirt MJ, Woodworth GF, Coon AL, Frazier JM, Amundson E, Garonzik I, et al. Independent predictors of morbidity after imageguid- ed stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg 2005;102:897-901.
  7. Shastri-Hurst N, Tsegaye M, Robson DK, Lowe JS, Macarthur DC: Stereotactic brain biopsy: an audit of sampling reliability in a clinical case series. Br J Neu- rosurg 2006;20:222-6.
  8. Smith JS, Quinã ones-Hinojosa A, Barbaro NM, McDermott MW. Frame-based stereotactic biopsy remains an important diagnostic tool with distinct advantages over frameless stereotactic biopsy. J Neuro Oncol 2005;73:173-9.
  9. Woodworth G, McGirt MJ, Samdani A, Garonzik I, Olivi A, Weingart JD. Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen. Neurol Res 2005;27:358-62.
  10. Shooman D, Belli A, Grundy PL: Image-guided frameless stereotactic biopsy without intraoperative neuropathological examination. J Neurosurg 2010;113:170-8.
  11. Chandrasoma PT, Smith MM, Apuzzo ML. Stereo- tactic biopsy in the diagnosis of brain masses: com- parison of results of biopsy and resected surgical specimen. Neurosurgery 1989;24:160-5.
  12. Jackson RJ, Fuller GN, Abi-Said D, Lang FF, Gokaslan ZL, Shi WM, et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol 2001;3:193-200.
  13. McGirt MJ, Villavicencio AT